Early research (Phase 1)Study completedNCT00060645
What this trial is testing
Safety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED)
Who this might be right for
TumorsLymphomaMultiple Myeloma
Merck Sharp & Dohme LLC 33